Cervical Intraepithelial Neoplasia clinical trials

Explore recruiting cervical intraepithelial neoplasia clinical trials.

Recruiting cervical intraepithelial neoplasia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cervical Intraepithelial Neoplasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy of pre-surgical HPV9-valente vaccination in women treated with loop electrosurgical excision (LEEP) for high-grade cervical intraepithelial neoplasia (CIN2+) up to cervical cancer initially invasive (FIGO IA1) - HOPE 9 STUDY

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

A Registry-Based Extension of Protocol V503-001 in Countries with Centralized Cervical Cancer Screening Infrastructures to Evaluate the Long-Term Effectiveness, immunogenicity, and Safety of Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine as Administered to 16- to 26- Year- Old Women.

Norway, Sweden, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cervical Intraepithelial Neoplasia trials by city

Cervical Intraepithelial Neoplasia in Toronto Cervical Intraepithelial Neoplasia in Vancouver Cervical Intraepithelial Neoplasia in Montreal Cervical Intraepithelial Neoplasia in Calgary Cervical Intraepithelial Neoplasia in Edmonton Cervical Intraepithelial Neoplasia in Ottawa Cervical Intraepithelial Neoplasia in Winnipeg Cervical Intraepithelial Neoplasia in Quebec City Cervical Intraepithelial Neoplasia in Hamilton Cervical Intraepithelial Neoplasia in Kitchener Cervical Intraepithelial Neoplasia in London Cervical Intraepithelial Neoplasia in Halifax Cervical Intraepithelial Neoplasia in New York Cervical Intraepithelial Neoplasia in Los Angeles Cervical Intraepithelial Neoplasia in Chicago Cervical Intraepithelial Neoplasia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease